Drug Eye Africa

Gabon gives pharmaceutical establishments three months to obtain technical licence

The Ministry of Health of Gabon has announced that all pharmaceutical establishments operating without technical approval must regularise their status within three months.

The notice, signed by Minister of Health Professor Elsa Nkana Joséphine AYO épouse BIVIGOU on 16 November 2026, invokes Article 307 of Law No. 030/2025 of 5 January 2026 establishing the Health Code, and Article 7 of Ordinance No. 001/PR/2011 of 27 January 2011 on the organisation of the pharmaceutical sector in the Republic of Gabon, ratified by Law No. 18/2011 of 14 February 2012.

These provisions make the opening and operation of any pharmaceutical establishment conditional upon obtaining prior technical approval from the Minister of Health.

All pharmaceutical establishments nationwide that do not yet hold this approval must comply with the regulatory requirement within three months of the publication date of the communiqué. The authority did not state the exact publication date or when the three-month period expires.

After this deadline, any establishment in irregular situation will be exposed to the administrative and penal sanctions provided for by the legislative and regulatory texts in force.

Source: Ministry of Health of Gabon, Communiqué No. 003288 MS/CAB-M, 16 November 2026: http://www.anmaps.ga/documents/6afdb7af1a383_REGULARISATION18112026.pdf

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top